Loading stock data…
Loading stock data…
US$0.00
Get one email when PXMD crosses your level. Checked every 15 minutes during market hours.
▼ -0.00 (-28.57%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
45.4
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.00
Bullish momentumMACD above its signal line (0.00).
50-day average
0.00
Price belowShort-term trend reference.
200-day average
0.00
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
PaxMedica Inc. is a clinical-stage biopharmaceutical company primarily focused on developing therapeutics for the treatment of complex neurological and developmental disorders. The company is heavily engaged in the research and development of innovative drug therapeutics aimed at addressing autism spectrum disorder and related conditions. PaxMedica Inc. leverages its expertise in the field to create compounds that target the specific biological pathways implicated in these disorders, seeking to …
www.paxmedica.com| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-03-18 | 2.51 | 2.69 | ✓ Beat |
| 2026-02-26 | 0.32 | 0.34 | ✓ Beat |
| 2024-05-13 | -0.43 | -0.5 | ✗ Miss |
| 2024-03-11 | -0.88 | -1.45 | ✗ Miss |
| 2022-11-13 | — | -0.87 | — |
Companies in the same industry, via Finnhub